Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium cromoglicate for diarrhea-predominant irritable bowel syndrome
2007-005914-38Phase 4Active
- Sponsor
- Vall d'Hebron University Hospital - Digestive Diseases Department
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sodium cromoglycate in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Vall d'Hebron University Hospital - Digestive Diseases Department. Primary endpoint: Proportion of patients with significant clinical improvement. Started Mar 2008; status: active.
02
Drugs
sodium cromoglycate
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2007-005914-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005914-38.